Physiotherapy for Hip and Knee Pain

N/A

Waitlist Available

Led By Jordan Miller, PhD

Research Sponsored by Queen's University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3, 6, 9, and 12 months follow-up

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a new way for physiotherapists to lead the care for hip and knee pain in Canada to see how it affects patients and the healthcare system.

Who is the study for?

This trial is for individuals experiencing hip and knee pain due to osteoarthritis. It's designed to assess a new way of care where physiotherapists lead the treatment in primary care settings, compared to the usual physician-led approach.

What is being tested?

The study is testing a new model where physiotherapists take charge of primary care for patients with hip and knee osteoarthritis, versus the traditional method led by physicians. The impact on patient health and healthcare systems will be measured.

What are the potential side effects?

Since this trial involves non-drug interventions (physiotherapy vs. standard medical care), typical medication side effects are not expected. However, some participants might experience discomfort or fatigue related to physical therapy sessions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3, 6, 9, and 12 months follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3, 6, 9, and 12 months follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3, 6, 9, and 12 months follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Self-Reported Functioning

Secondary study objectives

Adverse Events

Assistance Needed

Catastrophic Thinking

+27 more

Other study objectives

Baseline Characteristics

Chronicity of Pain

Comorbidities

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Physiotherapist-led primary care model for hip and knee painExperimental Treatment1 Intervention

The index intervention will incorporate a PT within the primary care team and make them available at the first point of contact for people with hip or knee pain. There will be 4 key components of this intervention: 1) Initial assessment and screening; 2) Brief individualized intervention at first visit; 3) Health services navigation; 4) Providing additional PT care for people with an unmet need (e.g., no insurance coverage for PT).

Group II: Usual physician-led primary care model for hip and knee painActive Control1 Intervention

Participants will be seen by a primary care physician or a nurse practitioner, depending on the current practice at the clinic. Participants in both groups will be permitted to seek additional care outside of the primary care clinic.

Do I qualify?Apply below to find out